{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:45:31Z","timestamp":1791380731145,"version":"4.3.3"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.canlet.2025.217443","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T20:16:32Z","timestamp":1736021792000},"page":"217443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Role of Cathepsin K in bone invasion of pituitary adenomas: A dual mechanism involving cell proliferation and osteoclastogenesis"],"prefix":"10.1016","volume":"611","author":[{"given":"Hongyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-645X","authenticated-orcid":false,"given":"Weijun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.canlet.2025.217443_bib1","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.7150\/thno.53749","article-title":"Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217443_bib2","article-title":"Revised-knosp, and hardy-wilson classifications for the prediction of surgical outcomes in the endoscopic endonasal surgery of pituitary adenomas: study of 228 cases","volume":"11","author":"Araujo-Castro","year":"2021","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2025.217443_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","article-title":"Aggressive pituitary tumours and pituitary carcinomas","volume":"17","author":"Raverot","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217443_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3174\/ajnr.A2364","article-title":"Clival invasion on multi-detector CT in 390 pituitary macroadenomas: correlation with sex, subtype and rates of operative complication and recurrence","volume":"32","author":"Chen","year":"2011","journal-title":"AJNR. Am. J. Neuroradiol."},{"issue":"22","key":"10.1016\/j.canlet.2025.217443_bib5","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1158\/1078-0432.CCR-18-0472","article-title":"Functions and mechanisms of tumor necrosis factor-\u03b1 and noncoding RNAs in bone-invasive pituitary adenomas","volume":"24","author":"Zhu","year":"2018","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217443_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101056","article-title":"Drug resistance mechanisms in dopamine agonist-resistant prolactin pituitary neuroendocrine tumors and exploration for new drugs","volume":"73","author":"Cheng","year":"2024","journal-title":"Drug Resist. Updates"},{"issue":"12","key":"10.1016\/j.canlet.2025.217443_bib7","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1535-7163.MCT-14-0253","article-title":"Efficacy of a cathepsin K inhibitor in a preclinical model for prevention and treatment of breast cancer bone metastasis","volume":"13","author":"Duong","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"issue":"11","key":"10.1016\/j.canlet.2025.217443_bib8","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/s41418-019-0312-y","article-title":"Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.canlet.2025.217443_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1359\/jbmr.2003.18.2.222","article-title":"Cathepsin K mRNA and protein expression in prostate cancer progression","volume":"18","author":"Brubaker","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2025.217443_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13104-015-1284-8","article-title":"Matrix-metalloproteinase-9 is cleaved and activated by cathepsin K","volume":"8","author":"Christensen","year":"2015","journal-title":"BMC Res. Notes"},{"issue":"9","key":"10.1016\/j.canlet.2025.217443_bib11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1515\/hsz-2013-0134","article-title":"Cathepsin K: a unique collagenolytic cysteine peptidase","volume":"394","author":"Novinec","year":"2013","journal-title":"Biol. Chem."},{"issue":"6","key":"10.1016\/j.canlet.2025.217443_bib12","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2174\/1874467214666210211162118","article-title":"Inhibitory effects of cathepsin K inhibitor (ODN-MK-0822) on the paracrine pro-osteoclast factors of breast cancer cells","volume":"14","author":"Vashum","year":"2021","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217443_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mehy.2016.10.013","article-title":"The association between Cathepsin K expression and sphenoid sinus invasion of pituitary adenomas","volume":"97","author":"Liu","year":"2016","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.canlet.2025.217443_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","article-title":"Targeting mTOR for cancer therapy","volume":"12","author":"Hua","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217443_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"18","key":"10.1016\/j.canlet.2025.217443_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25184136","article-title":"The potential role of cathepsin K in non-small cell lung cancer","volume":"25","author":"Yang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.canlet.2025.217443_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216657","article-title":"Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer","volume":"587","author":"Zhao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217443_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216020","article-title":"mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53flox\/+LSL-KrasG12D\/+Pdx-1-Cre murine models","volume":"554","author":"Qiu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217443_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216643","article-title":"HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer","volume":"584","author":"Wu","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.canlet.2025.217443_bib20","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2018-02461","article-title":"Effect of Everolimus in treatment of aggressive prolactin-secreting pituitary adenomas","volume":"104","author":"Zhang","year":"2019","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"7753","key":"10.1016\/j.canlet.2025.217443_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41586-019-1105-7","article-title":"Developmental origin, functional maintenance and genetic rescue of osteoclasts","volume":"568","author":"Jacome-Galarza","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.canlet.2025.217443_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002703","article-title":"Osteoprotegerin in bone metastases: mathematical solution to the puzzle","volume":"8","author":"Ryser","year":"2012","journal-title":"PLoS Comput. Biol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217443_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020695","article-title":"Elevated expression of cathepsin K in periodontal ligament fibroblast by inflammatory cytokines accelerates osteoclastogenesis via paracrine mechanism in periodontal disease","volume":"22","author":"Heo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2025.217443_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr. Pathol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217443_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/EJE-10-0255","article-title":"Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients","volume":"163","author":"Brochier","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.canlet.2025.217443_bib26","article-title":"Expression and clinical significance of Cathepsin K and MMPs in invasive non-functioning pituitary adenomas","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217443_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2014.11.025","article-title":"14-3-3\u03b6 turns TGF-\u03b2's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2","volume":"27","author":"Xu","year":"2015","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.canlet.2025.217443_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41388-021-02088-7","article-title":"Inhibition of cathepsin K sensitizes oxaliplatin-induced apoptotic cell death by Bax upregulation through OTUB1-mediated p53 stabilization in vitro and in vivo","volume":"41","author":"Seo","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217443_bib29","article-title":"The role of Raptor in lymphocytes differentiation and function","volume":"14","author":"Tang","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217443_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4161\/cc.7.3.5267","article-title":"mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase","volume":"7","author":"Ghosh","year":"2008","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.canlet.2025.217443_bib31","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1128\/MCB.01389-12","article-title":"Ubiquitin hydrolase UCH-L1 destabilizes mTOR complex 1 by antagonizing DDB1-CUL4-mediated ubiquitination of raptor","volume":"33","author":"Hussain","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217443_bib32","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3389\/fimmu.2019.01663","article-title":"Finding a toll on the route: the fate of osteoclast progenitors after toll-like receptor activation","volume":"10","author":"Souza","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217443_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102336","article-title":"BAP1 phosphorylation-mediated Sp1 stabilization plays a critical role in cathepsin K inhibition-induced C-terminal p53-dependent Bax upregulation","volume":"53","author":"Seo","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217443_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12022-018-9563-2","article-title":"The prognostic roles of the ki-67 proliferation index, P53 expression, mitotic index, and radiological tumor invasion in pituitary adenomas","volume":"30","author":"Hasanov","year":"2019","journal-title":"Endocr. Pathol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217443_bib35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/cen.13402","article-title":"Predictors for secondary therapy after surgical resection of nonfunctioning pituitary adenomas","volume":"87","author":"Ratnasingam","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"10.1016\/j.canlet.2025.217443_bib36","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.3390\/curroncol29080471","article-title":"Cathepsin K: a versatile potential biomarker and therapeutic target for various cancers","volume":"29","author":"Qian","year":"2022","journal-title":"Curr. Oncol."},{"issue":"22","key":"10.1016\/j.canlet.2025.217443_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213762","article-title":"Cathepsin K in pathological conditions and new therapeutic and diagnostic perspectives","volume":"23","author":"Mijanovi\u0107","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.canlet.2025.217443_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/CS20190584","article-title":"Role of the Nox4\/AMPK\/mTOR signaling axe in adipose inflammation-induced kidney injury","volume":"134","author":"Njeim","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"issue":"24","key":"10.1016\/j.canlet.2025.217443_bib39","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1021\/acs.jmedchem.2c01070","article-title":"Targeting the PI3K\/AKT\/mTOR signaling pathway in the treatment of human diseases: current status, trends, and solutions","volume":"65","author":"Huang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217443_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216511","article-title":"PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt\/mTOR-mediated Ca2+ flux","volume":"581","author":"Sun","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217443_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216518","article-title":"Unveiling autophagy complexity in leukemia: the molecular landscape and possible interactions with apoptosis and ferroptosis","volume":"582","author":"Jung","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2025.217443_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110892","article-title":"Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks","volume":"441","author":"Magnuson","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2025.217443_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2015.07.006","article-title":"Ribosomal protein S6 phosphorylation: four decades of research","volume":"320","author":"Meyuhas","year":"2015","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"20","key":"10.1016\/j.canlet.2025.217443_bib44","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.2174\/0929867329666220224112042","article-title":"The mTOR\/4E-BP1\/eIF4E signalling pathway as a source of cancer drug targets","volume":"29","author":"Maracci","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2025.217443_bib45","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1038\/s41467-021-23285-8","article-title":"PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling","volume":"12","author":"Ma","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.canlet.2025.217443_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/er.2015-1114","article-title":"Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned","volume":"38","author":"Drake","year":"2017","journal-title":"Endocr. Rev."},{"issue":"Pt 4","key":"10.1016\/j.canlet.2025.217443_bib47","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/BST0350701","article-title":"Cathepsin K in the bone microenvironment: link between obesity and prostate cancer?","volume":"35","author":"Podgorski","year":"2007","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.canlet.2025.217443_bib48","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00432-019-02950-y","article-title":"Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone","volume":"145","author":"Liang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217443_bib49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2025.217443_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/nyas.12709","article-title":"Enhanced osteoclastogenesis by mitochondrial retrograde signaling through transcriptional activation of the cathepsin K gene","volume":"1364","author":"Guha","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.canlet.2025.217443_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123139","article-title":"Inhibitory effects of 2N1HIA (2-(3-(2-fluoro-4-methoxyphenyl)-6-oxo-1(6H)-Pyridazinyl)-N-1H-Indol-5-Ylacetamide) on osteoclast differentiation via suppressing cathepsin K expression","volume":"23","author":"Ahn","year":"2018","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.canlet.2025.217443_bib52","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ptr.5374","article-title":"Inhibition of osteoclast differentiation by ginsenoside Rg3 in RAW264.7 cells via RANKL, JNK and p38 MAPK pathways through a modulation of cathepsin K: an in silico and in vitro study","volume":"29","author":"Siddiqi","year":"2015","journal-title":"Phytother Res. : PTR"},{"issue":"2","key":"10.1016\/j.canlet.2025.217443_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/mc.1067","article-title":"Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides","volume":"32","author":"Ishikawa","year":"2001","journal-title":"Mol. Carcinog."},{"issue":"2","key":"10.1016\/j.canlet.2025.217443_bib54","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbrc.2012.12.003","article-title":"Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblasts","volume":"430","author":"Hirabara","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.canlet.2025.217443_bib55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCRESAHA.108.182568","article-title":"Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K","volume":"104","author":"Sun","year":"2009","journal-title":"Circ. Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:00:16Z","timestamp":1760742016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525000072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":55,"alternative-id":["S0304383525000072"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217443","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Cathepsin K in bone invasion of pituitary adenomas: A dual mechanism involving cell proliferation and osteoclastogenesis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217443"}}